BioCentury
ARTICLE | Company News

GZMO, Genzyme Genetics IP deal

January 2, 2002 8:00 AM UTC

Genzyme Molecular (GZMO) transferred its cancer diagnostics IP to Genzyme Genetics, a business unit of Genzyme (GENZ). Genzyme Genetics ( Cambridge, Mass.) will have rights to cancer markers and cance...